Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: Results from two pivotal clinical trials

医学 鼻腔给药 交叉研究 基础(医学) 刺激 随机对照试验 麻醉 眼科 内科学 病理 药理学 安慰剂 替代医学 胰岛素
作者
John D. Sheppard,Gail Torkildsen,Joel A. Geffin,Jung Dao,David G. Evans,George W Ousler,Jasmine Wilson,Stephanie N. Baba,Michelle Senchyna,Edward J. Holland
出处
期刊:Ocular Surface [Elsevier BV]
卷期号:17 (1): 142-150 被引量:31
标识
DOI:10.1016/j.jtos.2018.11.009
摘要

The intranasal tear neurostimulator (ITN) activates the nasolacrimal pathway, which is involved with basal and bolus tear secretion. These studies characterized the acute and long-term effectiveness of the ITN in stimulating tear production in subjects with dry eye disease (DED). Study 1: Randomized, double-masked, dual-controlled, 1-day crossover. Study 2: Single-arm, open-label, 180-day prospective cohort. Eligible subjects had basal unstimulated Schirmer test (with anesthesia) ≤10 mm and intranasal cotton swab–stimulated Schirmer test at least 7 mm greater in the same eye, and Ocular Surface Disease Index® ≥13 and ≥ 23, in Studies 1 and 2, respectively. Study 1: Subjects (n = 48) received three randomized test applications: active intranasal, extranasal (active control), and sham intranasal (inactive control) stimulation, 3 min/application with 1-hour minimum between applications. Primary outcome measure was the difference in Schirmer test scores during active intranasal and control applications. Study 2: Subjects (n = 97) performed intranasal neurostimulation for ≤3 min/application, 2–10 times/day. Primary outcome measure was the difference in Schirmer scores (stimulated minus unstimulated) at day 180. Both studies recorded device-related adverse events (AEs). Study 1: Schirmer scores (mean ± SEM) were significantly greater (p < 0.0001) with active intranasal (25.3 ± 1.5 mm) vs extranasal (9.5 ± 1.2 mm) and sham (9.2 ± 1.1 mm) applications. Study 2: Schirmer scores were significantly greater (p < 0.0001) with ITN stimulation vs unstimulated at day 180 (17.3 ± 1.3 mm vs 7.9 ± 0.7 mm). No serious device-related AEs were reported in either study. The ITN was well-tolerated and effective in stimulating tear production with acute and long-term use in DED. NCT02680158 and NCT02526290.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
我不到啊完成签到 ,获得积分10
2秒前
3秒前
朴实无招完成签到,获得积分10
4秒前
随风飘远完成签到 ,获得积分10
8秒前
8秒前
丸子完成签到 ,获得积分10
9秒前
桃子完成签到 ,获得积分10
9秒前
lei.qin完成签到 ,获得积分10
10秒前
cyan完成签到 ,获得积分10
11秒前
LQY完成签到 ,获得积分10
16秒前
态度完成签到 ,获得积分10
17秒前
18秒前
等待念之完成签到,获得积分10
18秒前
赘婿的应助被tianmengkui采纳,获得10
22秒前
23秒前
小呱完成签到 ,获得积分10
24秒前
璇璇完成签到 ,获得积分10
26秒前
拓跋幻枫完成签到,获得积分10
29秒前
29秒前
兰彻完成签到,获得积分10
29秒前
老六完成签到 ,获得积分10
30秒前
勋章完成签到 ,获得积分10
30秒前
唐陌完成签到 ,获得积分10
32秒前
鱼鱼鱼鱼完成签到 ,获得积分10
33秒前
危机的棒棒糖完成签到,获得积分10
35秒前
韭黄完成签到,获得积分10
38秒前
39秒前
tianmengkui完成签到,获得积分10
41秒前
macrossfev完成签到,获得积分10
43秒前
47秒前
韭菜完成签到,获得积分10
47秒前
情怀的应助被tianmengkui采纳,获得10
47秒前
Willwzh完成签到,获得积分10
47秒前
yx完成签到 ,获得积分10
50秒前
52秒前
Sun1c7完成签到,获得积分10
55秒前
新帅完成签到,获得积分10
55秒前
完犊子完成签到,获得积分10
57秒前
浪漫小窗完成签到,获得积分10
57秒前
58秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190360
求助须知:如何正确求助?哪些是违规求助? 9577423
关于积分的说明 21852492
捐赠科研通 7788942
什么是DOI,文献DOI怎么找? 3436315
关于科研通互助平台的介绍 2560144
邀请新用户注册赠送积分活动 2482995